Stéphane Bancel, Moderna CEO (Endpoints JPM)
Moderna puts a seasonal flu vaccine in the clinic as execs hope to open chapter 2 of their blockbuster vaccine story
Moderna initiated a Phase I/II study today aimed at seeing just how well it can do in fielding a future vaccine that could target a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
